Cid12 is a poly(A) polymerase involved in RNA interference (RNAi)-mediated heterochromatin assembly and chromosome segregation. Key findings include:
Function:
In a study of immunocompromised patients with RAG mutations, "CID-12" refers to a patient with combined immune deficiency (CID) who developed neutralizing anti-cytokine antibodies (e.g., anti-TNF-α) . This nomenclature is unrelated to antibodies as reagents.
The search results include references to other antibodies, but none target "CID12":
CID12 functions as a poly(A) polymerase involved in RNA interference (RNAi)-mediated heterochromatin assembly and chromosome segregation in Schizosaccharomyces pombe (fission yeast). This protein plays a critical role in maintaining genomic stability through its involvement in the RNAi pathway. The key properties of CID12 include:
| Property | Description |
|---|---|
| Organism | Schizosaccharomyces pombe (fission yeast) |
| Molecular Role | Poly(A) polymerase, RNAi pathway component |
| Mutant Phenotypes | Chromosome segregation defects, meiotic abnormalities, checkpoint failure |
| Dependencies | Requires Bub1 spindle checkpoint protein for viability |
Understanding these fundamental properties is essential for researchers designing experiments with CID12 antibodies, as they inform potential research applications and expected cellular responses.
Current research resources include commercially available CID12 antibodies such as those produced by Cusabio (product code: CSB-PA797571XA01DOA) . These antibodies are designed for detecting CID12 in experimental settings focused on RNA processing and chromosome maintenance mechanisms. When selecting an antibody for CID12 research, considerations should include specificity, host species compatibility, and validated applications in relevant model systems.
When using CID12 antibodies in research protocols, several methodological considerations must be addressed to ensure experimental validity. While specific optimization may be required for each research context, general recommendations include:
Sample Preparation: Cell lysis buffers containing protease inhibitors are recommended to preserve CID12 protein integrity during extraction.
Western Blot Applications: When performing western blot analysis, researchers should optimize antibody dilution ratios, typically starting with manufacturer recommendations (similar to the 1:500-1:3000 range used for comparable antibodies) .
Immunoprecipitation Considerations: For co-immunoprecipitation studies examining CID12 interactions with other RNAi components, gentle lysis conditions are advised to maintain protein-protein interactions.
Cross-Reactivity Assessment: Before proceeding with critical experiments, validation of antibody specificity against potential cross-reactive proteins is essential, particularly when working with conserved RNA processing machinery.
For researchers investigating RNAi mechanisms using CID12 antibodies, specialized experimental approaches have proven valuable:
Chromatin Immunoprecipitation (ChIP) Protocols: When examining CID12 associations with heterochromatic regions, ChIP protocols must account for the transient nature of these interactions. Crosslinking optimization is particularly important for capturing these interactions.
RNA Immunoprecipitation (RIP) Techniques: For studying CID12's interaction with RNA substrates, RIP techniques can be employed with careful attention to preserving RNA integrity during the procedure.
Combined Approaches: Integration of CID12 antibody-based detection with RNA sequencing provides comprehensive insights into the functional targets of this poly(A) polymerase in the RNAi pathway.
Researchers working with CID12 antibodies may encounter several technical challenges that require systematic troubleshooting:
Specificity Validation: Given the role of CID12 in RNA processing machinery which contains numerous related proteins, antibody cross-reactivity must be carefully assessed through proper controls, including:
Competitive blocking with recombinant CID12
Testing in CID12 knockout/knockdown systems
Comparison with alternative antibody clones
Signal Optimization: When signal strength is insufficient, researchers should consider:
Signal amplification systems
Extended incubation periods
Alternative detection methods
Background Reduction: High background signal can be addressed through:
Increased blocking agent concentration
Additional washing steps
Careful antibody titration
When designing experiments utilizing CID12 antibodies, researchers should incorporate several quality control measures:
Researchers investigating chromosome segregation mechanisms can utilize CID12 antibodies to:
Visualize Centromeric Localization: Immunofluorescence protocols can reveal CID12 recruitment to centromeric regions during cell division, providing insights into its role in chromosome segregation.
Detect Interactions with Checkpoint Proteins: Co-immunoprecipitation using CID12 antibodies can identify interactions with spindle checkpoint proteins like Bub1, which has been shown to functionally interact with CID12.
Assess Modifications During Cell Cycle: Western blot analysis using CID12 antibodies can reveal potential post-translational modifications that regulate CID12 activity during different cell cycle phases.
For researchers working on evolutionary conservation of RNAi mechanisms:
Cross-Species Reactivity: While CID12 antibodies are primarily designed for detecting the S. pombe protein, careful epitope analysis may reveal potential cross-reactivity with functional homologs in related species.
Complementation Studies: CID12 antibodies can be valuable tools in studies examining functional complementation between CID12 and related proteins from other organisms.
Emerging research opportunities involving CID12 antibodies include:
Super-Resolution Microscopy: Application of techniques like STORM or PALM with CID12 antibodies could reveal previously undetectable spatial organization of RNAi machinery.
Live Cell Imaging: Development of compatible tagging strategies that don't interfere with antibody recognition could enable dynamic studies of CID12 localization.
Correlative Light and Electron Microscopy (CLEM): Combining CID12 antibody detection with ultrastructural analysis offers potential for placing CID12 function in the context of nuclear architecture.
While primarily a research tool, understanding CID12 antibody applications has broader implications:
Model Systems for Genomic Instability: CID12's role in chromosome segregation means antibodies against this protein can help investigate mechanisms of genomic instability relevant to human disease.
Comparative Studies with Human Homologs: CID12 antibodies may inform research on functional human counterparts involved in RNA processing and genome stability maintenance.